LV10251B - Method of preparation of hypuric acid salts of 4-(di-n-propyl)amino-6-aminocarbonil-1,3,4,5-tetrahydrobenz£c,d|indole - Google Patents

Method of preparation of hypuric acid salts of 4-(di-n-propyl)amino-6-aminocarbonil-1,3,4,5-tetrahydrobenz£c,d|indole

Info

Publication number
LV10251B
LV10251B LVP-93-509A LV930509A LV10251B LV 10251 B LV10251 B LV 10251B LV 930509 A LV930509 A LV 930509A LV 10251 B LV10251 B LV 10251B
Authority
LV
Latvia
Prior art keywords
tetrahydrobenz
propyl
amino
preparation
indole
Prior art date
Application number
LVP-93-509A
Other languages
English (en)
Other versions
LV10251A (lv
Inventor
Thomas Joseph Kress
David Lee Varie
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LV10251A publication Critical patent/LV10251A/xx
Publication of LV10251B publication Critical patent/LV10251B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LVP-93-509A 1990-02-26 1993-06-08 Method of preparation of hypuric acid salts of 4-(di-n-propyl)amino-6-aminocarbonil-1,3,4,5-tetrahydrobenz£c,d|indole LV10251B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48518590A 1990-02-26 1990-02-26

Publications (2)

Publication Number Publication Date
LV10251A LV10251A (lv) 1994-10-20
LV10251B true LV10251B (en) 1995-04-20

Family

ID=23927224

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-509A LV10251B (en) 1990-02-26 1993-06-08 Method of preparation of hypuric acid salts of 4-(di-n-propyl)amino-6-aminocarbonil-1,3,4,5-tetrahydrobenz£c,d|indole

Country Status (28)

Country Link
US (1) US5397799A (he)
EP (1) EP0444852B1 (he)
JP (1) JP3157007B2 (he)
KR (1) KR100208114B1 (he)
CN (1) CN1027503C (he)
AT (1) ATE126506T1 (he)
AU (1) AU629453B2 (he)
BR (1) BR9100767A (he)
CA (1) CA2037099C (he)
CY (1) CY1887A (he)
DE (1) DE69112099T2 (he)
DK (1) DK0444852T3 (he)
ES (1) ES2077796T3 (he)
FI (1) FI95464C (he)
GR (1) GR3017940T3 (he)
HK (1) HK175495A (he)
HU (1) HU217118B (he)
IE (1) IE67801B1 (he)
IL (1) IL97306A (he)
LV (1) LV10251B (he)
NO (1) NO174149C (he)
NZ (1) NZ237181A (he)
PT (1) PT96852B (he)
RU (2) RU2034837C1 (he)
SG (1) SG69975A1 (he)
TW (1) TW219933B (he)
YU (1) YU47594B (he)
ZA (1) ZA911258B (he)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97309A (he) * 1990-02-26 1996-11-14 Lilly Co Eli חומרי ביניים להקסהידרובנז ][ dc אינדולים ותהליך להכנת אננטייומרים טהורים שלהם
US5302612A (en) * 1990-02-26 1994-04-12 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
IL97308A (he) * 1990-02-26 1996-10-31 Lilly Co Eli הקסאהידרובנז ]dc[ אינדולים מותמרים בעמדה 6, תהליך להכנתם ותכשירי רוקחות המכילים אותם
US5633273A (en) * 1991-03-28 1997-05-27 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd] indoles
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
TW248556B (he) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
US7588924B2 (en) 2006-03-07 2009-09-15 Procter & Gamble Company Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase
WO2008002576A2 (en) 2006-06-26 2008-01-03 The Procter & Gamble Company Prolyl hydroxylase inhibitors and methods of use
PT2496084E (pt) 2009-11-06 2015-08-21 Aerpio Therapeutics Inc Métodos para aumentar a estabilização de fator-1 alfa indutivel por hipoxia
NO2686520T3 (he) 2011-06-06 2018-03-17
CA2837560C (en) 2011-06-06 2017-02-14 Akebia Therapeutics Inc. Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
AU2014278543B2 (en) 2013-06-13 2019-11-14 Akebia Therapeutics, Inc. Compositions and methods for treating anemia
AR099354A1 (es) 2013-11-15 2016-07-20 Akebia Therapeutics Inc Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos
AU2016209126A1 (en) 2015-01-23 2017-08-10 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
BR112017021097B1 (pt) 2015-04-01 2024-01-02 Akebia Therapeutics, Inc Formulação de dosagem oral e seu uso
CA3097219A1 (en) 2018-05-09 2019-11-14 Akebia Therapeutics, Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles

Also Published As

Publication number Publication date
CA2037099A1 (en) 1991-08-27
AU629453B2 (en) 1992-10-01
ES2077796T3 (es) 1995-12-01
JPH04217662A (ja) 1992-08-07
YU47594B (sh) 1995-10-24
HUT56542A (en) 1991-09-30
IE67801B1 (en) 1996-05-01
HK175495A (en) 1995-11-24
CY1887A (en) 1996-04-05
EP0444852A3 (en) 1992-02-19
AU7197191A (en) 1991-08-29
BR9100767A (pt) 1991-10-29
CN1027503C (zh) 1995-01-25
FI910895A (fi) 1991-08-27
PT96852B (pt) 1998-07-31
IL97306A0 (en) 1992-05-25
EP0444852B1 (en) 1995-08-16
FI95464C (fi) 1996-02-12
LV10251A (lv) 1994-10-20
DE69112099D1 (de) 1995-09-21
NO174149C (no) 1994-03-23
RU2034837C1 (ru) 1995-05-10
JP3157007B2 (ja) 2001-04-16
KR910021375A (ko) 1991-12-20
DE69112099T2 (de) 1996-02-08
YU32791A (sh) 1994-01-20
KR100208114B1 (ko) 1999-07-15
IE910625A1 (en) 1991-08-28
GR3017940T3 (en) 1996-02-29
SG69975A1 (en) 2000-01-25
IL97306A (he) 1996-10-16
TW219933B (he) 1994-02-01
NO910735L (no) 1991-08-27
FI910895A0 (fi) 1991-02-25
ZA911258B (en) 1992-10-28
ATE126506T1 (de) 1995-09-15
US5397799A (en) 1995-03-14
EP0444852A2 (en) 1991-09-04
CA2037099C (en) 2001-09-11
NZ237181A (en) 1992-06-25
FI95464B (fi) 1995-10-31
NO174149B (no) 1993-12-13
CN1054589A (zh) 1991-09-18
HU217118B (hu) 1999-11-29
NO910735D0 (no) 1991-02-25
RU2083561C1 (ru) 1997-07-10
DK0444852T3 (da) 1995-12-11
PT96852A (pt) 1991-10-31

Similar Documents

Publication Publication Date Title
LV10251B (en) Method of preparation of hypuric acid salts of 4-(di-n-propyl)amino-6-aminocarbonil-1,3,4,5-tetrahydrobenz£c,d|indole
IE782325L (en) TETRAHYDROBENZ £cd| INDOLES
AU2378988A (en) 4-(N-3-pyridylmethyl)-amino-1,2,4-triazinones
TW239862B (he)
AU7941691A (en) Antimigraine alkoxypyrimidine derivatives
EP0276543A3 (en) Use of buspirone for the improvement of short term memory
RU92004575A (ru) Кристаллическая соль 4-(ди-н-пропил) амино-6-аминокарбонил-1,3,4,5-тетрагидробенз (cd) индола и ее 4p и 4s-изомеры
AU623688B2 (en) Substituted 1,4-dihydro-4-oxo-1-pyrodinyl- (quinoline or naphthyridine) derivatives
AU597017B2 (en) 3-(2-aminoethyl) indoles derivatives
EP0462837A3 (en) Preparation of indole derivatives
AU7418887A (en) Indole derivatives
PH23992A (en) Optically active 2,3-dihydrobenzoxazine derivatives and process for preparing the same
AU590603B2 (en) A method of preparing indoles or indole derivatives, coupled via position 4, 5, 6, or 7, the indoles or indole derivatives concerned, as well as the use thereof
AU609159B2 (en) Method of sterilizing anthers utilizing carboxylic acid derivatives
AU2803689A (en) Certain 3-substituted 2- alkyl indole derivatives
AU609158B2 (en) Method of sterilizing anthers utilizing substituted maleamino acids
GB9024172D0 (en) Method of generating an'i.c.inserted'signal automatically for an i.c.socket
PL274219A1 (en) Method of obtaining novel derivatives of 4-oxo-1,2,3,4-tetrahydrocinnoline